fda
8 records
FDA Drug Recall: GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Onl
2024-05-01
Class II — Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified ...
View Source
FDA Drug Recall: FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per c
2024-05-01
Class II — Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified ...
View Source
FDA Drug Recall: GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Onl
2024-05-01
Class II — Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified ...
View Source
FDA Drug Recall: FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein),
2024-05-01
Class II — Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified ...
View Source
FDA Drug Recall: Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodi
2021-05-26
Class III — Subpotent Drug
View Source
FDA Drug Recall: Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, ind
2015-04-29
Class III — Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the...
View Source
FDA Drug Recall: Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluore
2015-04-29
Class III — Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the...
View Source
FDA Drug Recall: Fluorescein Sodium Ophthalmic Strips USP, 1.0 mg per strip, labeled as 1) FUL-GL
2015-04-29
Class III — Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the...
View Source
fda_adverse
3 records
FDA AE Manufacturer: Nomax Inc.
Drug adverse event reporter — Product: POTASSIUM BICARBONATE
View Source
ny_corps
2 records
NY Corp: NOMAX, INC.
2016-03-25
FOREIGN BUSINESS CORPORATION | County: New York | Jurisdiction: Missouri
View Source
NY Corp: NOMAX GROUP, LLC
2007-04-13
DOMESTIC LIMITED LIABILITY COMPANY | County: Queens | Jurisdiction: New York
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.